| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.5M | -46.2% |
| R&D Expense | $11.8M | -12.4% |
| SG&A Expense | $4.2M | -1.3% |
| Operating Income | -$12.9M | -15.9% |
| Pre-tax Income | -$12.2M | -14.0% |
| Income Tax | -$15K | -130.3% |
| Net Income | -$12.2M | -13.3% |
| EPS (Basic) | -$0.79 | +33.6% |
| EPS (Diluted) | -$0.79 | +33.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.1M | -16.3% |
| Current Assets | $19.1M | -13.4% |
| Total Assets | $19.1M | -13.4% |
| Current Liabilities | $2.3M | -34.4% |
| Total Liabilities | $2.3M | -34.4% |
| Stockholders' Equity | $16.8M | -9.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.0M | -10.1% |
| Financing Cash Flow | $9.9M | -34.2% |